Ambu A/S (CPH:AMBU.B)
Denmark · Delayed Price · Currency is DKK 65.75
+0.25 (0.38%)
Sep 18, 2026, 4:59 PM CET
Ambu A/S Market Cap
Ambu A/S has a market cap or net worth of 17.16 billion as of September 18, 2026. Its market cap has decreased by -33.71% in one year.
Market Cap
17.16B
Enterprise Value
17.04B
Revenue
6.24B
Ranking
n/a
PE Ratio
34.25
Stock Price
65.75
ChartMarket Cap Chart
Since August 8, 1994, Ambu A/S's market cap has increased from 290.04M to 17.16B, an increase of 5,817.76%. That is a compound annual growth rate of 13.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 17.16B | -26.71% |
| Dec 30, 2025 | 23.42B | -15.47% |
| Dec 30, 2024 | 27.70B | -1.11% |
| Dec 29, 2023 | 28.01B | 23.89% |
| Dec 30, 2022 | 22.61B | -48.49% |
| Dec 30, 2021 | 43.90B | -32.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.24T |
| Genmab | 132.12B |
| Coloplast | 94.44B |
| Demant | 63.10B |
| ALK-Abelló | 44.15B |
| H. Lundbeck | 40.93B |
| Zealand Pharma | 18.59B |
| Bavarian Nordic | 15.25B |